Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Meinl

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Journal of Neurology|March 18, 2005
Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell responseTobias Derfuss, Reinhard Hohlfeld, Edgar Meinl
Current Opinion in Neurology|June 8, 2022
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyondSimone Mader, Tania Kümpfel, Edgar Meinl
Journal of the Neurological Sciences|August 19, 2008
B- and T-cell responses in multiple sclerosis: novel approaches offer new insightsReinhard Hohlfeld, Edgar Meinl, Klaus Dornmair
Neurology|July 20, 2007
Dual role of inflammation in CNS diseaseReinhard Hohlfeld, Martin Kerschensteiner, Edgar Meinl
Nature Reviews. Neurology|December 15, 2010
The emerging role of microRNAs in multiple sclerosisAndreas Junker, Reinhard Hohlfeld, Edgar Meinl
Current Opinion in Neurology|April 19, 2020
Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseasesSimone Mader, Tania Kümpfel, Edgar Meinl
Frontiers in Immunology|June 6, 2018
Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic RelevanceAtay Vural, Kathrin Doppler, Edgar Meinl
Results and Problems in Cell Differentiation|April 4, 2009
Neuro-immune crosstalk in CNS diseasesMartin Kerschensteiner, Edgar Meinl, Reinhard Hohlfeld
The Journal of Pathology|February 20, 2020
MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiologySarah Teuber-Hanselmann, Edgar Meinl, Andreas Junker
Journal of the Neurological Sciences|June 1, 2012
Viability of autoantibody-targets: how to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosisMarie Cathrin Mayer, Reinhard Hohlfeld, Edgar Meinl
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Journal of Neurology|March 18, 2005
Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell responseTobias Derfuss, Reinhard Hohlfeld, Edgar Meinl
Current Opinion in Neurology|June 8, 2022
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyondSimone Mader, Tania Kümpfel, Edgar Meinl
Journal of the Neurological Sciences|August 19, 2008
B- and T-cell responses in multiple sclerosis: novel approaches offer new insightsReinhard Hohlfeld, Edgar Meinl, Klaus Dornmair
Neurology|July 20, 2007
Dual role of inflammation in CNS diseaseReinhard Hohlfeld, Martin Kerschensteiner, Edgar Meinl
Nature Reviews. Neurology|December 15, 2010
The emerging role of microRNAs in multiple sclerosisAndreas Junker, Reinhard Hohlfeld, Edgar Meinl
Current Opinion in Neurology|April 19, 2020
Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseasesSimone Mader, Tania Kümpfel, Edgar Meinl
Frontiers in Immunology|June 6, 2018
Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic RelevanceAtay Vural, Kathrin Doppler, Edgar Meinl
Results and Problems in Cell Differentiation|April 4, 2009
Neuro-immune crosstalk in CNS diseasesMartin Kerschensteiner, Edgar Meinl, Reinhard Hohlfeld
The Journal of Pathology|February 20, 2020
MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiologySarah Teuber-Hanselmann, Edgar Meinl, Andreas Junker
Journal of the Neurological Sciences|June 1, 2012
Viability of autoantibody-targets: how to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosisMarie Cathrin Mayer, Reinhard Hohlfeld, Edgar Meinl
Pageof 12